Naringenin (300 μM over a period of 24 h) decreased AKT and MMP-2 activities and inhibited migration of TSGH-8301 bladder cancer cells [100] and proliferation of A549 lung cancer cells [40]. The gene discussed is MMP2; the disease is lung cancer.